AllSight
Companies · CORZ · Finance Services · Other events · Sep 10, 2026

Core Scientific wins conditional ERCOT clearance for 1.4 GW, but Pecos remains pending

ERCOT approvalspartly known
1,402 MW conditionally approved across Denton, Pecos and Hunt
Core Scientific, Inc./tx (CORZ) — what happened, in plain English, and what it means versus what the market expected.

The market was expecting classifications, not a clean all-clear. ERCOT’s Batch Zero process had already signaled that applicant classifications would be issued around August 2026, so the existence of an update was largely anticipated rather than a surprise. The new information is the site-by-site outcome and how much capacity received conditional approval.

SitePower coveredERCOT statusWhat it means
Denton371 MW297 MW existing load outside Batch Zero; 74 MW additional power also outside Batch ZeroLowest execution risk of the three sites (Denton discussion)
Pecos600 MW300 MW existing load plus 300 MW studied load conditionally approved in Batch ZeroFinal allocation and ramp remain pending (Pecos discussion)
Hunt431 MWConditionally approved as advancing large load under Pathway (e)Strongest procedural position, with construction already underway (Hunt discussion)
Total1,402 MWConditionally approved or validatedMeaningful de-risking, but not final energization approval

Denton is effectively de-risked from the new queue. Its existing 297 MW was classified as longstanding existing load, while the additional 74 MW had already been validated in ERCOT’s 2025 transmission-plan studies and is not subject to Batch Zero. 〔0〕 That is better than an unresolved queue outcome because the capacity avoids the main allocation bottleneck.

Hunt received the most constructive classification. The full planned 431 MW was conditionally approved under the pathway for projects that have demonstrated maturity and advancement. The company says required studies and collateral are complete, long-lead equipment is ordered, and construction has begun. 〔1〕 This does not make the power fully operational, but it supports the credibility of the Hunt development timeline.

Pecos is the remaining qualification risk. The site received conditional approval for 600 MW, but half of that is classified as studied load and the filing explicitly says Core Scientific will not receive the final allocation or load ramp until Batch Zero concludes. 〔2〕 That keeps the headline capacity intact while preventing the filing from being treated as final confirmation of when all 600 MW can be energized.

Net: modestly better than the standing expectation, but not a full commercial milestone. Across the three sites, the filing converts a large amount of planned Texas capacity into conditional ERCOT-approved capacity, with Denton and Hunt in particularly strong positions. The limitation is that the approvals remain conditional and Pecos still lacks its final allocation and ramp schedule, so this is incremental de-risking rather than a completed power-delivery event.

Read the original 8-K on SEC EDGAR ↗
More from Core Scientific, Inc./tx (CORZ)
Aug 27, 2026Core Scientific adds $600M bank facility, but only $100M is cash liquidityAug 14, 2026The deal closed—but Core Scientific paid more than first disclosedAll CORZ filings, decoded →
Related companies in Finance Services
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact